Asian Pacific Society of Respirology (APSR) 21st Congress 2016
Bangkok, Thailand, 12 – 15 November
ABSTRACTS
Effectiveness of once-daily indacaterol/glycopyrronium (IND/GLY) with other combinations of inhaled maintenance therapies for COPD: the LUMIERE study design
Price D, Mezzi K, Roche N, Decuypere L, Molimard M, et al.
Respirology 2016; 21(Suppl 3): 188. Abstract ID – APSR6-0522.
[Full Text]
Real-life effects of switching LABA/ICS dry powder inhalers to formoterol/fluticasone in Korean asthma patients: the TRANSFFORM study
Price D, Park HS, Yoon D, Lee HY, Wan Yau Ming S, et al.
Respirology 2016; 21(Suppl 3): 22. Abstract ID – APSR6-0791.
[Full Text]
Real-life characteristics of asthma inhaler device use in South Korea
Wan Yau Ming S, Rhee CK, Park HY, Yoo KH, Kim DK, et al.
Respirology 2016; 21(Suppl 3): 170. Abstract ID – APSR6-0779.
[Full Text]
EVENT PHOTOS
@OPRI_SG
David Price, Jadwiga Wedzicha and Chin Kook Rhee discussing #FLAME #COPD #Ultibro #Breezhaler @APSRapsr
David Price, Jadwiga Wedzicha and Chin Kook Rhee discussing #FLAME #COPD #Ultibro #Breezhaler @APSRapsr pic.twitter.com/o04YOP5jU1
— OPRI (@OPRI_SG) November 13, 2016
@OPRI_SG
Prof David Price discussing groundbreaking new data on #COPD and #asthma at #APSR2016 @RespirologyAPSR
Prof David Price discussing groundbreaking new data on #COPD and #asthma at #APSR2016 @RespirologyAPSR pic.twitter.com/lLG0Aeiq8F
— OPRI (@OPRI_SG) November 13, 2016
@OPRI_SG
Omar Usmani, David Price and #mundipharma Chris Chen on inhaler app technology @APSRapsr: Improve technique, adherence and patient outcomes!
Omar Usmani, David Price and #mundipharma Chris Chen on inhaler app technology @APSRapsr: Improve technique, adherence and patient outcomes! pic.twitter.com/Mi6ZYwR74c
— OPRI (@OPRI_SG) November 13, 2016